| #337 |
Stefan RYSER |
Trellis Bioscience |
1 |
| #337 |
G. Mani Subramanian |
Gilead Sciences |
1 |
| #337 |
Anthony Joonkyoo Yun |
Palo Alto Investors Lp |
1 |
| #337 |
Mahnush Movahedi |
Dfinity Stiftung |
1 |
| #337 |
Alexander L. Huang |
Liveleaf Holdings |
1 |
| #337 |
Ronald Williams |
Myoscience |
1 |
| #337 |
Jeffrey Brian Straubel |
Tesla |
1 |
| #337 |
Konstantin Pervyshev |
Google |
1 |
| #337 |
Evan Minamoto |
Palantir Technologies |
1 |
| #337 |
Christopher Michael Bonner |
Imi Intelligent Medical Implants Ag |
1 |
| #337 |
Alonzo Canada |
Thoughtspot |
1 |
| #337 |
Seth Malmersjö |
Ngm Biopharmaceuticals |
1 |
| #337 |
Zoltan Gyongyi |
Google |
1 |
| #337 |
C. Garrison Fathman |
Stanford University |
1 |
| #337 |
Joann Jung |
AMD |
1 |
| #337 |
Kim Rubin |
Zetta Research And Development Llc—Forc Series |
1 |
| #337 |
Dorna KASHEFHAGHIGHI |
Illumina |
1 |
| #337 |
Domingo Mihovilovic |
Exabeam |
1 |
| #337 |
Troy Mestler |
Skyfront |
1 |
| #337 |
Sean T. Burns |
Hansen International |
1 |
| #337 |
Thaddeus S. Block |
Corcept Therapeutics Incorporated |
1 |
| #337 |
Kevin Sheridan |
Apple |
1 |
| #337 |
Matthew Siegel |
Anwita Biosciences |
1 |
| #337 |
Jason Harris |
Personalis |
1 |
| #337 |
David Evan Zlotnik |
Zoox |
1 |